M
MoonLake Immunotherapeutics
NASDAQ:MLTX
MoonLake Immunotherapeutics
NASDAQ:MLTX
Price:
14.77
USD
-1.73%
Market Closed
Market Cap:
$1.1B
Cash Flow Statement
Cash Flow Statement
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics
Currency: USD
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(70)
|
(54)
|
(62)
|
(65)
|
(61)
|
(56)
|
(53)
|
(44)
|
(46)
|
(58)
|
(83)
|
(121)
|
(148)
|
(179)
|
(214)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
|
| Stock-Based Compensation |
11
|
14
|
16
|
10
|
10
|
9
|
8
|
7
|
6
|
7
|
7
|
7
|
8
|
9
|
11
|
|
| Other Non-Cash Items |
16
|
13
|
13
|
10
|
11
|
9
|
8
|
8
|
7
|
7
|
9
|
7
|
8
|
7
|
9
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
|
| Change in Working Capital |
4
|
(3)
|
(3)
|
(1)
|
(0)
|
4
|
2
|
(6)
|
(10)
|
(14)
|
(6)
|
(4)
|
(1)
|
3
|
16
|
|
| Cash from Operating Activities |
(49)
N/A
|
(44)
+10%
|
(52)
-16%
|
(56)
-8%
|
(51)
+9%
|
(42)
+17%
|
(42)
+0%
|
(43)
-2%
|
(49)
-14%
|
(64)
-32%
|
(80)
-25%
|
(117)
-45%
|
(140)
-20%
|
(166)
-19%
|
(186)
-12%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
(42)
|
(32)
|
(13)
|
0
|
(132)
|
(25)
|
(73)
|
(174)
|
59
|
(205)
|
(120)
|
56
|
86
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+29%
|
(42)
-84 420%
|
(32)
+23%
|
(13)
+61%
|
0
N/A
|
(132)
N/A
|
(25)
+81%
|
(74)
-192%
|
(174)
-136%
|
59
N/A
|
(206)
N/A
|
(121)
+41%
|
55
N/A
|
86
+54%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
28
|
1
|
0
|
0
|
0
|
451
|
451
|
482
|
535
|
84
|
84
|
53
|
0
|
0
|
1
|
|
| Net Issuance of Debt |
30
|
0
|
0
|
(15)
|
(30)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
73
|
73
|
73
|
|
| Other |
0
|
135
|
135
|
135
|
0
|
0
|
0
|
(3)
|
(4)
|
(4)
|
(4)
|
(1)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
58
N/A
|
135
+132%
|
135
0%
|
120
-11%
|
105
-13%
|
451
+331%
|
451
N/A
|
480
+6%
|
531
+11%
|
79
-85%
|
80
+0%
|
51
-36%
|
73
+43%
|
73
N/A
|
74
+0%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
1
|
1
|
|
| Net Change in Cash |
9
N/A
|
91
+929%
|
41
-55%
|
31
-23%
|
41
+31%
|
409
+890%
|
277
-32%
|
412
+49%
|
408
-1%
|
(159)
N/A
|
57
N/A
|
(271)
N/A
|
(187)
+31%
|
(36)
+81%
|
(25)
+31%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(49)
N/A
|
(44)
+10%
|
(52)
-16%
|
(56)
-8%
|
(51)
+9%
|
(42)
+17%
|
(42)
+0%
|
(43)
-2%
|
(49)
-14%
|
(65)
-32%
|
(81)
-25%
|
(117)
-44%
|
(140)
-20%
|
(167)
-19%
|
(186)
-11%
|
|
Switch to:
Switch to:
See Also
Discover More
